Profantova B, rimal V, Profant V, Socha O, Barvik I, Stepankova H
RSC Adv. 2024; 14(51):38253-38267.
PMID: 39628460
PMC: 11613138.
DOI: 10.1039/d4ra05897f.
Zahm A, Owens W, Himes S, Fallon B, Rondem K, Gormick A
Nat Commun. 2024; 15(1):10353.
PMID: 39609378
PMC: 11604768.
DOI: 10.1038/s41467-024-54502-9.
Wong D, Qiu H
Vascul Pharmacol. 2024; 157():107443.
PMID: 39586415
PMC: 11648470.
DOI: 10.1016/j.vph.2024.107443.
Iwanski J, Pappas C, Mayfield R, Farman G, Ahrens-Nicklas R, Churko J
NPJ Regen Med. 2024; 9(1):21.
PMID: 39285234
PMC: 11405699.
DOI: 10.1038/s41536-024-00366-y.
Zhu Z, Guo Y, Liu Y, Ding R, Huang Z, Yu W
Adv Sci (Weinh). 2023; 10(32):e2303378.
PMID: 37786278
PMC: 10646254.
DOI: 10.1002/advs.202303378.
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.
Darbo E, Perot G, Darmusey L, Le Guellec S, Leroy L, Gaston L
Cancers (Basel). 2023; 15(2).
PMID: 36672483
PMC: 9856933.
DOI: 10.3390/cancers15020534.
Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases.
Tang H, Chen A, Zhang H, Gao X, Kong X, Zhang J
Cells. 2022; 11(24).
PMID: 36552822
PMC: 9777337.
DOI: 10.3390/cells11244060.
Transforming Growth Factor-β Receptor-Mediated, p38 Mitogen-Activated Protein Kinase-Dependent Signaling Drives Enhanced Myofibroblast Differentiation during Skin Wound Healing in Mice Lacking Hyaluronan Synthases 1 and 3.
Wang Y, Mack J, Hascall V, Maytin E
Am J Pathol. 2022; 192(12):1683-1698.
PMID: 36063901
PMC: 9765314.
DOI: 10.1016/j.ajpath.2022.08.003.
SRF in Neurochemistry: Overview of Recent Advances in Research on the Nervous System.
Tabuchi A, Ihara D
Neurochem Res. 2022; 47(9):2545-2557.
PMID: 35668335
DOI: 10.1007/s11064-022-03632-x.
Soluble Epoxide Hydrolase Inhibitors Regulate Ischemic Arrhythmia by Targeting MicroRNA-1.
Chen Y, Liu Q, Yang T, Shen L, Xu D
Front Physiol. 2021; 12:717119.
PMID: 34646152
PMC: 8502875.
DOI: 10.3389/fphys.2021.717119.
The Critical Role of Growth Factors in Gastric Ulcer Healing: The Cellular and Molecular Mechanisms and Potential Clinical Implications.
Tarnawski A, Ahluwalia A
Cells. 2021; 10(8).
PMID: 34440733
PMC: 8392882.
DOI: 10.3390/cells10081964.
Engineering combinatorial and dynamic decoders using synthetic immediate-early genes.
Ravindran P, Wilson M, Jena S, Toettcher J
Commun Biol. 2020; 3(1):436.
PMID: 32792645
PMC: 7426417.
DOI: 10.1038/s42003-020-01171-1.
Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas.
Tian S, Jing R, Zhang W
Front Oncol. 2020; 10:1001.
PMID: 32714860
PMC: 7343963.
DOI: 10.3389/fonc.2020.01001.
lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR‑125a‑5p.
Liu Y, Li M, Yu H, Piao H
Int J Mol Med. 2020; 45(2):497-509.
PMID: 31894257
PMC: 6984795.
DOI: 10.3892/ijmm.2019.4428.
Regulation of SRF protein stability by an autophagy-dependent pathway.
Luo J, Jin F, Yin M, Jin Z
Biochem Biophys Res Commun. 2019; 521(2):279-284.
PMID: 31668369
PMC: 7043231.
DOI: 10.1016/j.bbrc.2019.09.104.
Signaling from Neural Impulses to Genes.
Fields R
Neuroscientist. 2019; 2(6):315-325.
PMID: 31244519
PMC: 6594406.
In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis.
Tagalakis A, Madaan S, Larsen S, Neubig R, Khaw P, Rodrigues I
J Nanobiotechnology. 2018; 16(1):97.
PMID: 30482196
PMC: 6258153.
DOI: 10.1186/s12951-018-0425-3.
Emerging themes in neuronal activity-dependent gene expression.
Madabhushi R, Kim T
Mol Cell Neurosci. 2017; 87:27-34.
PMID: 29254824
PMC: 5894330.
DOI: 10.1016/j.mcn.2017.11.009.
Framework to function: mechanosensitive regulators of gene transcription.
Finch-Edmondson M, Sudol M
Cell Mol Biol Lett. 2017; 21:28.
PMID: 28536630
PMC: 5415767.
DOI: 10.1186/s11658-016-0028-7.
The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
Hermanns C, Hampl V, Holzer K, Aigner A, Penkava J, Frank N
Oncogene. 2017; 36(24):3464-3476.
PMID: 28114277
DOI: 10.1038/onc.2016.496.